CHK1 Regulates NF-κB signaling upon DNA damage in p53-deficient cells and associated tumor-derived microvesicles

8Citations
Citations of this article
24Readers
Mendeley users who have this article in their library.

Abstract

The recently discovered CHK1-Suppressed (CS) pathway is activated by inhibition or loss of the checkpoint kinase CHK1, promoting an apoptotic response to DNA damage mediated by caspase-2 in p53-deficient cells. Although functions of the CSpathway have been investigated biochemically, it remains unclear whether and how CHK1 inhibition can be regulated endogenously and whether this constitutes a key component of the DNA damage response (DDR). Here, we present data that define the first endogenous activation of the CS-pathway whereby, upon DNA damage, wild type p53 acts as an endogenous regulator of CHK1 levels that modulates caspase-2 activation. Moreover, we demonstrate that persistence of CHK1 levels in response to DNA damage in p53-deficient cancer cells, leads to CHK1-mediated activation of NF- κB and induction of NF-κB-regulated genes in cells and in associated tumor-derived microvesicles (TMVs), both of which are abrogated by loss or inhibition of CHK1. These data define a novel role for CHK1 in the DDR pathway as a regulator NF- κB activity. Our data provide evidence that targeting CHK1 in p53-deficient cancers may abrogate NF-κB signaling that is associated with increased cellular survival and chemoresistance.

Author supplied keywords

Cite

CITATION STYLE

APA

Carroll, B. L., Pulkoski-Gross, M. J., Hannun, Y. A., & Obeid, L. M. (2016). CHK1 Regulates NF-κB signaling upon DNA damage in p53-deficient cells and associated tumor-derived microvesicles. Oncotarget, 7(14), 18159–18170. https://doi.org/10.18632/oncotarget.7566

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free